End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 EUR | -.--% | +1.19% | -58.33% |
11:02am | Biophytis Files Investigational New Drug Application with US FDA for Mid-stage Obesity Drug Trial | MT |
10:31am | Biophytis: application filed in obesity in the USA | CF |
Sales 2024 * | - | Sales 2025 * | 4.8M 5.16M | Capitalization | 1.91M 2.05M |
---|---|---|---|---|---|
Net income 2024 * | -19M -20.42M | Net income 2025 * | -16M -17.2M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.4 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+1.22% | 22.78B | |
-11.14% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ALBPS Stock
- ALBPS Stock